Amyloid β-based therapy for Alzheimer's disease: Challenges, successes and future

Y Zhang, H Chen, R Li, K Sterling… - Signal transduction and …, 2023 - nature.com
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer's disease
(AD), and its accumulation has been considered as the molecular driver of Alzheimer's …

[HTML][HTML] Inflammation as a central mechanism in Alzheimer's disease

JW Kinney, SM Bemiller, AS Murtishaw… - Alzheimer's & Dementia …, 2018 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized
by cognitive decline and the presence of two core pathologies, amyloid β plaques and …

From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

WA Banks - Nature reviews Drug discovery, 2016 - nature.com
One of the biggest challenges in the development of therapeutics for central nervous system
(CNS) disorders is achieving sufficient blood–brain barrier (BBB) penetration. Research in …

Immune attack: the role of inflammation in Alzheimer disease

FL Heppner, RM Ransohoff, B Becher - Nature Reviews Neuroscience, 2015 - nature.com
The past two decades of research into the pathogenesis of Alzheimer disease (AD) have
been driven largely by the amyloid hypothesis; the neuroinflammation that is associated with …

Blood-brain barrier dysfunction and the pathogenesis of Alzheimer's disease

Y Yamazaki, T Kanekiyo - International journal of molecular sciences, 2017 - mdpi.com
Brain capillary endothelial cells form the blood-brain barrier (BBB), which is covered with
basement membranes and is also surrounded by pericytes and astrocyte end-feet in the …

Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer's disease brain: a review

X Zhan, B Stamova, FR Sharp - Frontiers in aging neuroscience, 2018 - frontiersin.org
This review proposes that lipopolysaccharide (LPS, found in the wall of all Gram-negative
bacteria) could play a role in causing sporadic Alzheimer's disease (AD). This is based in …

The role of inflammasomes in vascular cognitive impairment

L Poh, WL Sim, DG Jo, QN Dinh, GR Drummond… - Molecular …, 2022 - Springer
There is an increasing prevalence of Vascular Cognitive Impairment (VCI) worldwide, and
several studies have suggested that Chronic Cerebral Hypoperfusion (CCH) plays a critical …

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

BV Zlokovic - Nature Reviews Neuroscience, 2011 - nature.com
The neurovascular unit (NVU) comprises brain endothelial cells, pericytes or vascular
smooth muscle cells, glia and neurons. The NVU controls blood–brain barrier (BBB) …

The impact of microglial activation on blood-brain barrier in brain diseases

ACC da Fonseca, D Matias, C Garcia… - Frontiers in cellular …, 2014 - frontiersin.org
The blood-brain barrier (BBB), constituted by an extensive network of endothelial cells (ECs)
together with neurons and glial cells, including microglia, forms the neurovascular unit …

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

RD Bell, EA Winkler, I Singh, AP Sagare, R Deane… - Nature, 2012 - nature.com
Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4. APOE4 is a major
genetic risk factor for Alzheimer's disease, and is associated with Down's syndrome …